The Cosmetics Testing News

Follow the testing news dedicated to innovations and trends in the evaluation of active, ingredients, cosmetics and medical devices

  • Français

Eurofins Cosmetics & Personal Care Ensures Continuity of Activity

20 April 2020

The global network of testing facilities of Eurofins Cosmetics & Personal Care is fully committed to support our customers during the COVID-19 crisis. We are providing testing and services in the most effective manner possible, ensuring quality for our customers and safety for our staff and volunteers.

To that end, we are working hard to find solutions ensuring the continuity of our clinical activities (i.e: facilities in China, remote trials / remote examinations in other clinical laboratories).

Our Clinical Laboratory in Guangzhou (China) offers flexibility to our clinical studies, allowing us to continue to operate in full compliance with the requirements of the local authorities during the outbreak.

We are therefore proposing running special sessions in the next weeks to conduct your HRIPT test within our top-tier Clinical Laboratory in Guangzhou.

We are also continuing operations at our worldwide laboratories, albeit on a modified basis, including the following:

  • Regulatory & Toxicology services,
  • Physico-chemical analyses,
  • Microbiology testing,
  • Ecotoxicity & Biodegradability testing,
  • in vitro testing and remote audits.

Our teams are ready to support you during this period. If you have any questions about current or future needs, please do get in touch with us Cosmetics@eurofins.com

We look forward to the opportunity to assist you.

On behalf of all Eurofins employees, we thank you for your trust.

www.eurofins.com/cosmetics/